Wayne, PA, January 10, 2007 --(PR.com
)-- What: Free Webinar presentation discussing the FDA Part 15 Public Meeting held on December 18th, 2006.
When: Thursday, January 11th- 11am – 12pm EST.
Jim Walker, Chairman and CEO of Octagon Research Solutions, Inc a pioneer and leader in the electronic transformation of clinical R&D in the life sciences industry, announced today that Nancy Smerkanich, vice president of Regulatory Affairs at Octagon, will be the host of a free Webinar presentation which will discuss the FDA Part 15 Public Meeting held on December 18th, 2006.
Ms. Smerkanich will discuss the agency's questions that were posted to the docket and will share Octagon's informal survey results that were presented at the meeting.
This free Webinar presentation will provide:
- A brief description of the practical benefits and challenges of eCTD
- A thorough discussion of perceived time and costs associated with implementing the eCTD
- Insight into the status of eCTD implementation initiatives across the industry
- Octagon's analysis of the meeting and the practical implications to regulatory professionals
To register for this free Webinar please visit Octagon Research Solutions, Inc. website.
About Octagon’s Nancy Smerkanich:
Nancy Smerkanich, vice president of Regulatory Affairs at Octagon Research Solutions, Inc. is a frequently requested speaker at various industry conferences. Her practical expertise is sought after by large and small pharmaceutical organizations interested in gaining knowledge of the electronic regulatory submission landscape. She has participated in over 100 electronic submissions, has lead multiple tutorials and training programs and continues to provide leadership and actively participate in industry activities such as the Drug Information Association SIACs.
About Octagon Research Solutions, Inc.
Octagon is a pioneer and leading process-centric solutions provider that offers a suite of regulatory, clinical, process, and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. They leverage the power of electronic submissions through deep domain knowledge, cross-functional electronic submission expertise, a holistic process approach, and integrated solutions. Octagon is headquartered in Wayne, PA, with European headquarters in Amersham, UK. For more information please visit www.octagonresearch.com.